MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 355 filers reported holding MEDIVATION INC in Q3 2015. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $7,584,000 | +10.7% | 125,778 | -15.6% | 0.03% | +9.7% |
| Q1 2016 | $6,851,000 | -6.4% | 149,006 | -1.6% | 0.03% | -3.1% |
| Q4 2015 | $7,319,000 | +11.4% | 151,413 | -2.1% | 0.03% | +18.5% |
| Q3 2015 | $6,570,000 | -64.7% | 154,596 | -5.3% | 0.03% | -64.0% |
| Q2 2015 | $18,637,000 | -11.5% | 163,198 | 0.0% | 0.08% | -13.8% |
| Q1 2015 | $21,064,000 | +39.4% | 163,198 | +7.6% | 0.09% | +42.6% |
| Q4 2014 | $15,108,000 | +7.6% | 151,673 | +6.8% | 0.06% | +1.7% |
| Q3 2014 | $14,036,000 | +9.5% | 141,969 | -14.6% | 0.06% | +13.2% |
| Q2 2014 | $12,818,000 | +15.1% | 166,296 | -3.9% | 0.05% | +10.4% |
| Q1 2014 | $11,135,000 | +6.4% | 172,985 | +5.5% | 0.05% | +2.1% |
| Q4 2013 | $10,465,000 | +25.3% | 163,977 | +17.7% | 0.05% | +14.6% |
| Q3 2013 | $8,351,000 | -47.8% | 139,317 | -57.2% | 0.04% | -51.8% |
| Q2 2013 | $16,008,000 | – | 325,366 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |